FactaeThe Factual News

Innate Pharma: Analyst consensus rises sharply

Analysts significantly raise their targets for Innate Pharma.

Published 1sem1 sourceNotableupdated 4j
Lire en français
14s

The fact

The stock benefits from a capital increase and strengthened cash flow.

This momentum is attracting new investors on the Paris market.

Click the link to read an article on the topic:

Why it matters

Cette hausse du consensus pourrait soutenir le cours de l'action Innate Pharma, offrant une meilleure visibilité aux actionnaires actuels et potentiels.

Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
ParisWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on August 15, 2026
Back to home
Discover

Read more

All marches →